Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiologyHumansHypertensionEndothelin Receptor AntagonistsAntihypertensive AgentsPyrimidines
Aprocitentan in Resistant Hypertension: Mechanistic Insights, Clinical Evidence, and Future Directions.
Manoj Kumbhare, Bhagwan Rajendra Ide, Arshad Shaikh, Harshali Gode, Nishant Pagere
Published: 202510.62958/j.cjap.2025.030
Abstract
Resistant Hypertension is a significant clinical problem. It is found in the most of individuals who, even with the greatest multi-drug therapy, are not able to manage their blood pressure. A new dual endothelin receptor antagonist (ERA) called aproc…
Preview only. Read the full abstract at the source